| In vivo imaging of astrocytosis in Alzheimer’s disease: an 11C-L-deuteriodeprenyl and PIB PET study AF Santillo, JP Gambini, L Lannfelt, B Långström, L Ulla-Marja, L Kilander, ... European journal of nuclear medicine and molecular imaging 38, 2202-2208, 2011 | 81 | 2011 |
| Development of new PTK7-targeting aptamer-fluorescent and-radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept V Calzada, M Moreno, J Newton, J González, M Fernández, JP Gambini, ... Bioorganic & medicinal chemistry 25 (3), 1163-1171, 2017 | 42 | 2017 |
| Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model JP Gambini, P Cabral, O Alonso, E Savio, SD Figueroa, X Zhang, L Ma, ... Nuclear medicine and biology 38 (2), 255-260, 2011 | 42 | 2011 |
| 68Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin O Alonso, M Rodríguez-Taroco, E Savio, C Bentancourt, JP Gambini, ... Annals of nuclear medicine 28, 638-645, 2014 | 38 | 2014 |
| Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: case report with histopathological findings H Engler, I Nennesmo, E Kumlien, JP Gambini, PO Lundberg, ... International journal of clinical and experimental medicine 5 (2), 201, 2012 | 36 | 2012 |
| [99mTc (CO) 3]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model X Camacho, MF García, V Calzada, M Fernández, JA Chabalgoity, ... Oncology 84 (4), 200-209, 2013 | 28 | 2013 |
| Development of 99mTc (CO) 3-dendrimer-FITC for cancer imaging MR Tassano, PF Audicio, JP Gambini, M Fernandez, JP Damian, ... Bioorganic & medicinal chemistry letters 21 (18), 5598-5601, 2011 | 25 | 2011 |
| Biological evaluation of glucose and deoxyglucose derivatives radiolabeled with [99mTc (CO) 3 (H2O) 3]+ core as potential melanoma imaging agents R Dapueto, R Castelli, M Fernández, JA Chabalgoity, M Moreno, ... Bioorganic & medicinal chemistry letters 21 (23), 7102-7106, 2011 | 24 | 2011 |
| Technetium-99m-or Cy7-labeled rituximab as an imaging agent for non-Hodgkin lymphoma X Camacho, CL Machado, MF García, JP Gambini, A Banchero, ... Oncology 92 (4), 229-242, 2017 | 21 | 2017 |
| Glucosylated polymeric micelles actively target a breast cancer model N Lecot, R Glisoni, N Oddone, J Benech, M Fernández, JP Gambini, ... Advanced Therapeutics 4 (1), 2000010, 2021 | 19 | 2021 |
| Technetium glucose complexes as potential cancer imaging agents R Dapueto, RB Aguiar, M Moreno, CML Machado, FLN Marques, ... Bioorganic & Medicinal Chemistry Letters 25 (19), 4254-4259, 2015 | 18 | 2015 |
| Hybrid tracers and devices for intraoperative imaging: the future for radioguided surgery? JP Gambini, TP Quinn Clinical and Translational Imaging 4, 343-351, 2016 | 16 | 2016 |
| 99mTc-labeled Bevacizumab vía HYNIC for Imaging of Melanoma X Camacho, MF García, V Calzada, M Fernandez, O Alonso, JP Gambini, ... Journal of Analytical Oncology 3 (1), 53-64, 2014 | 16 | 2014 |
| Labeling and biological evaluation of 99mTc-HYNIC-Trastuzumab as a potential radiopharmaceutical for in vivo evaluation of HER2 expression in breast cancer V Calzada, F Garcia, M Fernández, W Porcal, T Quinn, O Alonso, ... World Journal of Nuclear Medicine 12 (1), 27, 2013 | 14 | 2013 |
| 99m Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: From bench to the bed side P Choudhury, E Savio, K Solanki, O Alonso, A Gupta, J Gambini, D Doval, ... World journal of nuclear medicine 11 (02), 47-56, 2012 | 14 | 2012 |
| In vivo visualization of somatostatin receptor expression with Ga-68-DOTA-TATE PET/CT in advanced metastatic prostate cancer O Alonso, JP Gambini, G Lago, J Gaudiano, A Quagliata, H Engler Clinical Nuclear Medicine 36 (11), 1063-1064, 2011 | 14 | 2011 |
| Evaluation of patients with head and neck cancer by means of 99mTc-glucarate JP Gambini, M Nunez, P Cabral, M Lafferranderie, J Noble, E Corchs, ... Journal of nuclear medicine technology 37 (4), 229-232, 2009 | 13 | 2009 |
| Preliminary in vivo characterization of a theranostic aptamer: Sgc8-c-DOTA-67Ga. V Calzada, J Báez, E Sicco, J Margenat, M Fernández, M Moreno, ... Aptamers 1, 2017 | 12 | 2017 |
| Preparation and primary bioevaluation of 99mTc-labeled-1-thio-β-D-Glucose as melanoma targeting agent R Castelli, M Fernandez, W Porcal, JP Gambini, O Alonso, A Chabalgoity, ... Current radiopharmaceuticals 4 (4), 355-360, 2011 | 12 | 2011 |
| Tocilizumab labeling with 99mTechnetium via HYNIC as a molecular diagnostic agent for multiple myeloma X Camacho, C Longo Machado, M Fernanda Garcia, M Fernández, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 11 | 2017 |
